ESR1 and breast cancer: Beyond breast cancer, three potentially-pathogenic ESR1 mutations were very recently identified in cervical squamous cell carcinoma samples [48]; thus, it would be interesting to use this highly sensitive and specific methodology in cervical cancer samples and potentially pre-malignant cases of endometriosis as well.